Instant NanoBiosensors Co., Ltd. is an award-winning Taiwanese start-up, specializing in the development of cutting-edge biosensor platforms. Established in 2016 by co-founder Tsun-Chih ''Tony'' Chung (CEO), Lai-Kwan Chau (PhD), and Shau-Chun ''Paul'' Wang (PhD), this aspiring biotechnology company operates on the mission to continuously improve biomedical research and diagnostic processes with simple, reliable and affordable detection solutions.
With the unique & patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance), the Light-Sensing Biomarker Analyzer platforms offer instant and accurate results for a variety of applications. By combining novel biomarkers with advantageous devices and biochips, we have the vision to revolutionize traditional immunoassays and diagnostic analyses for a more efficient healthcare ecosystem.
At Instant NanoBiosensors, we believe that Light Saves Lives.
To share our extensive experience and industry knowledge, since 2020, we have been offering a range of products under our business unit INvision that focuses on Genomics, Molecular Biology, and Precision Medicine. These products include high-quality automated nucleic acid purification platforms and precision medicine solutions.
公司介紹
奈捷生物科技股份有限公司是一家屢獲殊榮的台灣新創公司，專注於尖端光感測生物檢測器平台的開發。聯合創始人鍾尊智(CEO)、周禮君(博士)和王少君(博士)於2016年成立，這家有志於生物技術的公司，以簡單、可靠、實惠的檢測解決方案為使命，不斷精進生物醫學研究和診斷過程。
奈捷憑借獨特的專利技術FOPPR™（光纖粒子質譜共振），INB光感測生物檢測器平台為各種應用提供了即時準確的結果。通過將新穎之生物標記物，伴隨著光傳感設備的優勢與生物晶片專利技術相結合，期待達成我們的願景，以徹底改變傳統的免疫分析和診斷分析方式，以實現更高效的醫療生態系統。在奈捷生物科技，我們相信光能拯救生命。
自2020年起，我們依據著豐富的生命科學領域之市場經驗和知識，透過旗下品牌 INvision 提供專注於基因研究、分子生物學及精準醫療領域的產品，提供高品質的自動核酸純化平台與試劑耗材，以及精準醫療解決方案。
Contact
Us
Share
